Literature DB >> 12591125

Intra-accumbens pertussis toxin sensitizes rats to the locomotor activating effects of a single cocaine challenge.

Michele Hummel1, Ellen M Unterwald.   

Abstract

Drugs of abuse share common neurochemical signaling substrates, many of which are components of the cAMP cascade. Interestingly, a number of these substrates have been linked to drug-influenced behaviors. This study sought to understand the role of one signaling substrate, inhibitory G-proteins, in a drug-induced phenomenon known as behavioral sensitization. Specifically, we used pertussis toxin (PTX) as a tool to investigate the relationship between cocaine-induced alterations in cAMP signaling and behavior. Vehicle (1 micro l/side) or PTX (0.15 or 0.25 micro g/1 micro l/side) was bilaterally infused into the nucleus accumbens of rats. Locomotor activity was assessed on days 7, 14 and 21 post-infusion. Intra-accumbal PTX produced a dose-dependent increase in locomotor activity. On day 21 following behavioral monitoring for 1 h, rats were acutely challenged with cocaine (15 mg/kg, i.p.) and behavioral data were accumulated for an additional 2 h. Intra-accumbal PTX sensitized rats to the locomotor-activating effects of a single cocaine challenge which was dose-dependent. After behavioral testing, brains were removed and processed for in vitro receptor autoradiography using the D(1) receptor ligand [3H] SCH 23390. No changes in D(1) dopamine receptor binding were observed. These findings suggest a role for inhibitory proteins (G(i)/G(o)) within the nucleus acumbens in locomotor activity and also cocaine-induced behavioral sensitization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12591125     DOI: 10.1016/s0006-8993(02)04142-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

Review 1.  Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain.

Authors:  S Ferré; I Diamond; S R Goldberg; L Yao; S M O Hourani; Z L Huang; Y Urade; I Kitchen
Journal:  Prog Neurobiol       Date:  2007-05-01       Impact factor: 11.685

2.  Accelerated maternal responding following intra-VTA pertussis toxin treatment.

Authors:  John J Byrnes; Erin D Gleason; Matthew K Schoen; Mathew T Schoen; Dennis F Lovelock; Lindsay M Carini; Elizabeth M Byrnes; Robert S Bridges
Journal:  Behav Brain Res       Date:  2011-05-06       Impact factor: 3.332

3.  Levamisole and cocaine synergism: a prevalent adulterant enhances cocaine's action in vivo.

Authors:  Christopher S Tallarida; Erin Egan; Gissel D Alejo; Robert Raffa; Ronald J Tallarida; Scott M Rawls
Journal:  Neuropharmacology       Date:  2014-01-15       Impact factor: 5.250

4.  Levamisole enhances the rewarding and locomotor-activating effects of cocaine in rats.

Authors:  Christopher S Tallarida; Ronald J Tallarida; Scott M Rawls
Journal:  Drug Alcohol Depend       Date:  2015-02-07       Impact factor: 4.492

Review 5.  Activators of G-protein signaling 3: a drug addiction molecular gateway.

Authors:  Michael Scott Bowers
Journal:  Behav Pharmacol       Date:  2010-09       Impact factor: 2.293

6.  Alterations in the level of OFQ/N-IR in rat brain regions by cocaine.

Authors:  Kabirullah Lutfy; Hoa Lam; Shridhar Narayanan
Journal:  Neuropharmacology       Date:  2008-05-21       Impact factor: 5.250

7.  Activator of G protein signaling 3: a gatekeeper of cocaine sensitization and drug seeking.

Authors:  M Scott Bowers; Krista McFarland; Russell W Lake; Yuri K Peterson; Christopher C Lapish; Mary Lee Gregory; Stephen M Lanier; Peter W Kalivas
Journal:  Neuron       Date:  2004-04-22       Impact factor: 17.173

8.  L-isocorypalmine reduces behavioral sensitization and rewarding effects of cocaine in mice by acting on dopamine receptors.

Authors:  Wei Xu; Yujun Wang; Zhongze Ma; Yi-Ting Chiu; Peng Huang; Khampaseuth Rasakham; Ellen Unterwald; David Y-W Lee; Lee-Yuan Liu-Chen
Journal:  Drug Alcohol Depend       Date:  2013-09-02       Impact factor: 4.492

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.